ÂÜÀòÂÒÂ×

Nam Nhito is an experienced investment manager specializing in life sciences and venture capital, currently employed at Brandenburg Kapital GmbH since October 2020. In addition to this role, Nam serves on the boards of several organizations, including Captain T Cell, Seqstant GmbH, ThinkSono, Emperra GmbH E-Health Technologies, smedo GmbH, Caterna, and PAM Theragnostics GmbH. Nam also has board observer experience with Pentracor GmbH and has previously worked as an analyst in strategy and new business at Medicover. Nam holds two master's degrees in Industrial Engineering and Management and Pharmaceutical Bioprocess Engineering from the TUM School of Management and the Technical University of Munich, respectively, in addition to a bachelor's degree in Bioprocess Engineering from the Technical University of Munich. Academic credentials also include research internship experience at UCL and education at Seoul National University and Lund University.